{"id":7013,"date":"2022-03-17T15:10:42","date_gmt":"2022-03-17T15:10:42","guid":{"rendered":"https:\/\/www.adacyte.com\/developpement-clinique\/"},"modified":"2022-03-17T15:10:43","modified_gmt":"2022-03-17T15:10:43","slug":"developpement-clinique","status":"publish","type":"page","link":"https:\/\/www.adacyte.com\/fr\/developpement-clinique\/","title":{"rendered":"D\u00e9veloppement clinique"},"content":{"rendered":"<div class=\"max-w-mw mx-auto mb-25 px-25 lg:px-0\"><div class=\"post-content text-18-24 font-body text-blue-d lg:text-18-28 max-w-743 lg:pl-157\">\n<p>Chez Adacyte, nous nous engageons fermement \u00e0 d\u00e9velopper des relations durables et une confiance mutuelle avec les professionnels de sant\u00e9, les soci\u00e9t\u00e9s m\u00e9dicales et toutes les autres organisations, afin de concevoir et de mener des essais cliniques pertinents.<\/p>\n<\/div><\/div><div class=\"max-w-mw mx-auto mb-25 px-25 lg:px-0\"><div class=\"post-content text-18-24 font-body text-blue-d lg:text-18-28 max-w-743 lg:pl-157\">\n<p>Notre approche consiste \u00e0 maximiser la valeur th\u00e9rapeutique de nos dispositifs m\u00e9dicaux actuels et futurs, que ce soit en termes d\u2019indications d\u00e9j\u00e0 approuv\u00e9es ou pour r\u00e9pondre \u00e0 de nouveaux besoins m\u00e9dicaux encore insatisfaits \u00e0 ce jour.<\/p>\n<\/div><\/div><div class=\"max-w-mw mx-auto mb-25 px-25 lg:px-0\"><div class=\"post-content text-18-24 font-body text-blue-d lg:text-18-28 max-w-743 lg:pl-157\">\n<p>En 2020, Adacyte Therapeutics, en partenariat avec JIMRO (Japan Immunoresearch Laboratories Co., Ltd), a lanc\u00e9 un ambitieux programme de d\u00e9veloppement clinique de la GMA.<\/p>\n<\/div><\/div><div class=\"max-w-mw mx-auto mb-25 px-25 lg:px-0\"><div class=\"post-content text-18-24 font-body text-blue-d lg:text-18-28 max-w-743 lg:pl-157\">\n<p>Au cours des quatre ann\u00e9es \u00e0 venir, nous allons mener des essais cliniques pertinents en Europe et aux \u00c9tats-Unis, avec plus de 1\u00a0000 patients, 150 chercheurs et 80 h\u00f4pitaux universitaires.<\/p>\n<\/div><\/div>\n  <div class=\"w-full mb-45 lg:mb-75 px-25 pt-25 lg:pt-40\">\n    <div class=\"w-full mx-auto max-w-315 md:max-w-mw\">\n      <picture class=\"block w-full h-auto\">\n        <source media=\"(min-width: 768px)\" srcset=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2022\/02\/Adacyte_Pipeline_Desktop.jpg\" \/>\n        <img decoding=\"async\" class=\"block w-full h-auto\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2022\/02\/Adacyte_Pipeline_Mobile-2.jpg\" alt=\"\" title=\"Adacyte_Pipeline_Desktop\">\n      <\/picture>\n    <\/div>\n      <\/div>","protected":false},"excerpt":{"rendered":"<p>Chez Adacyte, nous nous engageons fermement \u00e0 d\u00e9velopper des relations durables et une confiance mutuelle avec les professionnels de sant\u00e9, les soci\u00e9t\u00e9s m\u00e9dicales et toutes les autres organisations, afin de concevoir et de mener des essais cliniques pertinents. Notre approche consiste \u00e0 maximiser la valeur th\u00e9rapeutique de nos dispositifs m\u00e9dicaux actuels et futurs, que ce [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-clinical-development.php","meta":{"footnotes":""},"class_list":["post-7013","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>D\u00e9veloppement clinique - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/clinical-development\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9veloppement clinique - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Chez Adacyte, nous nous engageons fermement \u00e0 d\u00e9velopper des relations durables et une confiance mutuelle avec les professionnels de sant\u00e9, les soci\u00e9t\u00e9s m\u00e9dicales et toutes les autres organisations, afin de concevoir et de mener des essais cliniques pertinents. Notre approche consiste \u00e0 maximiser la valeur th\u00e9rapeutique de nos dispositifs m\u00e9dicaux actuels et futurs, que ce [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/clinical-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-17T15:10:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/clinical-development\/\",\"url\":\"https:\/\/www.adacyte.com\/clinical-development\/\",\"name\":\"D\u00e9veloppement clinique - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2022-03-17T15:10:42+00:00\",\"dateModified\":\"2022-03-17T15:10:43+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/clinical-development\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"D\u00e9veloppement clinique - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/clinical-development\/","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9veloppement clinique - Adacyte","og_description":"Chez Adacyte, nous nous engageons fermement \u00e0 d\u00e9velopper des relations durables et une confiance mutuelle avec les professionnels de sant\u00e9, les soci\u00e9t\u00e9s m\u00e9dicales et toutes les autres organisations, afin de concevoir et de mener des essais cliniques pertinents. Notre approche consiste \u00e0 maximiser la valeur th\u00e9rapeutique de nos dispositifs m\u00e9dicaux actuels et futurs, que ce [&hellip;]","og_url":"https:\/\/www.adacyte.com\/clinical-development\/","og_site_name":"Adacyte","article_modified_time":"2022-03-17T15:10:43+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/clinical-development\/","url":"https:\/\/www.adacyte.com\/clinical-development\/","name":"D\u00e9veloppement clinique - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2022-03-17T15:10:42+00:00","dateModified":"2022-03-17T15:10:43+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/clinical-development\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/pages\/7013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/comments?post=7013"}],"version-history":[{"count":0,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/pages\/7013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=7013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}